| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | ZnF_U1 | 1.84e-03 | 29 | 41 | 2 | SM00451 | |
| Domain | Znf_U1 | 1.84e-03 | 29 | 41 | 2 | IPR003604 | |
| Domain | Znf_FYVE_PHD | 4.09e-03 | 147 | 41 | 3 | IPR011011 | |
| Domain | Zinc_finger_PHD-type_CS | 8.96e-03 | 65 | 41 | 2 | IPR019786 | |
| Pubmed | The mouse ZFH-4 protein contains four homeodomains and twenty-two zinc fingers. | 1.42e-06 | 2 | 42 | 2 | 10873665 | |
| Pubmed | Subcellular localization of ATBF1 regulates MUC5AC transcription in gastric cancer. | 1.42e-06 | 2 | 42 | 2 | 17330845 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | 2.14e-06 | 724 | 42 | 8 | 36232890 | |
| Pubmed | 8.53e-06 | 4 | 42 | 2 | 23300874 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 3.60e-05 | 774 | 42 | 7 | 15302935 | |
| Pubmed | 3.97e-05 | 529 | 42 | 6 | 14621295 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 7.05e-05 | 861 | 42 | 7 | 36931259 | |
| Pubmed | 2.04e-04 | 1371 | 42 | 8 | 36244648 | ||
| Pubmed | 2.67e-04 | 20 | 42 | 2 | 35177643 | ||
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 4.48e-04 | 123 | 42 | 3 | 26912792 | |
| Pubmed | 5.28e-04 | 28 | 42 | 2 | 38324473 | ||
| Pubmed | 5.28e-04 | 28 | 42 | 2 | 29365100 | ||
| Pubmed | Interactome of vertebrate GAF/ThPOK reveals its diverse functions in gene regulation and DNA repair. | 6.05e-04 | 321 | 42 | 4 | 32098917 | |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | 6.63e-04 | 583 | 42 | 5 | 29844126 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 2.06e-04 | 15 | 26 | 2 | 529 | |
| GeneFamily | PHD finger proteins | 7.37e-03 | 90 | 26 | 2 | 88 | |
| Coexpression | LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2 | 7.94e-06 | 176 | 41 | 5 | M39223 | |
| Coexpression | CHANDRAN_METASTASIS_UP | 1.82e-05 | 209 | 41 | 5 | M16036 | |
| Coexpression | CHANDRAN_METASTASIS_TOP50_UP | 2.66e-05 | 37 | 41 | 3 | M18970 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.14e-06 | 224 | 39 | 6 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k1_1000 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-05 | 145 | 42 | 4 | 8da10bc6611976e1ec85e09f04a2dc5bf6555c9e | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_dendritic|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.63e-05 | 162 | 42 | 4 | 233011408f022647932c81ebab78f9813e3c6833 | |
| ToppCell | 356C-Myeloid-Dendritic-pDC|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.71e-05 | 164 | 42 | 4 | fed26f4ac36a2b0722bc7b9f91659c5e0cf4d53a | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.01e-05 | 171 | 42 | 4 | 4fd2c7977c512c51507f055fc74b111c0228ed8b | |
| ToppCell | COVID_vent-Lymphocytic-Dendritic-pDC|COVID_vent / Disease condition, Lineage, Cell class and subclass | 2.01e-05 | 171 | 42 | 4 | 779c951d274ecbd1d546ac425d6c8e718623be5a | |
| ToppCell | COVID_vent-Lymphocytic-Dendritic|COVID_vent / Disease condition, Lineage, Cell class and subclass | 2.01e-05 | 171 | 42 | 4 | debbb071d260639b16269c94d172766908325c58 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.31e-05 | 177 | 42 | 4 | da8802a6351d3e510822f82e2fde8a4314a2216e | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Stroma____kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.46e-05 | 180 | 42 | 4 | b6f44fdedc33b7d93b0074e8e9c8cc32009d4c4d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.52e-05 | 181 | 42 | 4 | 9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.57e-05 | 182 | 42 | 4 | eb138aa1dca9373f1586600f258df06dcf56d81f | |
| ToppCell | healthy_donor-Lymphocytic-Dendritic|healthy_donor / Disease condition, Lineage, Cell class and subclass | 2.80e-05 | 186 | 42 | 4 | 916f2aeea4989ba7a29e071e348a51010f010223 | |
| ToppCell | healthy_donor-Lymphocytic-Dendritic-pDC|healthy_donor / Disease condition, Lineage, Cell class and subclass | 2.80e-05 | 186 | 42 | 4 | 45f66619e45d590c7365a51782d4ac46b7d31fde | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.86e-05 | 187 | 42 | 4 | 5258674d0346e5c51a4b965efcdc1790c970845d | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.92e-05 | 188 | 42 | 4 | c32d023a69b6da79687ff8fa7485e7499db57046 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.92e-05 | 188 | 42 | 4 | 1cd5a4d744bd3777246958ea5eb94388a5cbad81 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Treg_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.92e-05 | 188 | 42 | 4 | b1ec7c45aedcc3d22cac898c6a3679e7f8b44c77 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.92e-05 | 188 | 42 | 4 | 874404a4fd9aa42873f6c53dc42da22d3b0fdb9e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.92e-05 | 188 | 42 | 4 | b21e93a70583c30d05c0833cd3d4d4bca44a039e | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.04e-05 | 190 | 42 | 4 | 1803b1e7c36285f9eaabc3c6e9a9752c5908db3d | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-MYL4+_SMC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.37e-05 | 195 | 42 | 4 | dba2a87efd7e067c094c4b367feb4138cab62735 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.37e-05 | 195 | 42 | 4 | 2e1df01bf6e4e98e6cd9fb50926e34c5077b8666 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-MYL4+_SMC|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.50e-05 | 197 | 42 | 4 | 4797f414330316e2ac2cf7cd2570d991877d7a38 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-IN_Progenitors|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 3.57e-05 | 198 | 42 | 4 | 3811d9e3e54bbe8b208c591697e43b55ab5bbf0e | |
| ToppCell | control-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.64e-05 | 199 | 42 | 4 | 3d01f90ffd271ca00129192787e4921bdca7e01e | |
| ToppCell | Thalamus|World / BrainAtlas - Mouse McCarroll V32 | 1.78e-04 | 116 | 42 | 3 | 5ddfb2dd5459ff6d7ae38163a38eae64fda283b7 | |
| ToppCell | RV-14._Fibroblast_III|RV / Chamber and Cluster_Paper | 3.10e-04 | 140 | 42 | 3 | b4fee8eb6bf855b364b00bda3f78e49d851bbca0 | |
| ToppCell | Children_(3_yrs)-Immune-mast_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.86e-04 | 151 | 42 | 3 | bbf735c6433c3fc2feedb24ed6f48c51d545fb60 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_11|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.17e-04 | 155 | 42 | 3 | fab281db4c275d51240b122be78713c839ba5a95 | |
| ToppCell | 356C-Myeloid-Dendritic-pDC|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.25e-04 | 156 | 42 | 3 | d9d87368e43b24952e70f31f38425e15b716ff5b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.41e-04 | 158 | 42 | 3 | 1cefb82b9bf79c687a119be568cfc15b14c6e040 | |
| ToppCell | COVID_non-vent-Lymphocytic-Dendritic-pDC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 4.58e-04 | 160 | 42 | 3 | 61f4cb4eb4313d8318aadbb99595a6cb7fd919f7 | |
| ToppCell | COVID_non-vent-Lymphocytic-Dendritic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 4.58e-04 | 160 | 42 | 3 | 34b4f710cfcb6ec370b8b074f3cbfe272f392cec | |
| ToppCell | Children_(3_yrs)-Immune-dendritic_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.66e-04 | 161 | 42 | 3 | cd41abb7ae659d3d314281783a0aaad562b26037 | |
| ToppCell | Children_(3_yrs)-Immune-dendritic_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.75e-04 | 162 | 42 | 3 | 86a0b9dabd150dc993bfc0f3344804de7f8e4042 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.92e-04 | 164 | 42 | 3 | 76b0ac220b7ca22fbea28a507f01f96ae9f53932 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.92e-04 | 164 | 42 | 3 | 911081739174ec68bc0893c804e4276b206bea7d | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.92e-04 | 164 | 42 | 3 | c5bfae7e9497185548c243d6f9ebadbcef48ba7f | |
| ToppCell | 356C-Fibroblasts-Fibroblast-D-|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.09e-04 | 166 | 42 | 3 | 7c2eee0a4f45795a956acf936b85bdb35f1b1624 | |
| ToppCell | Influenza_Severe-pDC|World / Disease group and Cell class | 5.09e-04 | 166 | 42 | 3 | bd25ce4c03c3d6cd9d986b9be1d355da52f0f2d7 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-D|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.09e-04 | 166 | 42 | 3 | 7286a37b2827f3747469ffd0d76cbe81116db7ee | |
| ToppCell | remission-HSPC|World / disease stage, cell group and cell class | 5.09e-04 | 166 | 42 | 3 | d269ee6f7adb55b05dcb5eaea96629ccb0b2d6e3 | |
| ToppCell | Influenza_Severe-pDC|Influenza_Severe / Disease group and Cell class | 5.09e-04 | 166 | 42 | 3 | b43a5cd4d28118cf6e56a435deb8ea9435608a90 | |
| ToppCell | mild_COVID-19_(asymptomatic)-pDC|World / disease group, cell group and cell class (v2) | 5.18e-04 | 167 | 42 | 3 | bf08f17965a4dd03f371b4ed0ab0d5e62ed61307 | |
| ToppCell | mild_COVID-19_(asymptomatic)-pDC|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 5.27e-04 | 168 | 42 | 3 | 968405ea56f7d001ef83ff9274610923c3b2d55d | |
| ToppCell | B_cells-pDCs|World / Immune cells in Kidney/Urine in Lupus Nephritis | 5.27e-04 | 168 | 42 | 3 | dc8f94424f60ab56facdcffa969e7f3466ee1b6e | |
| ToppCell | NS-moderate-d_07-13-Myeloid-pDC|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.27e-04 | 168 | 42 | 3 | d03e91f0e0518b33555c0ec98124fc5ed0f11be5 | |
| ToppCell | metastatic_Brain-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 5.27e-04 | 168 | 42 | 3 | 4bf3f85aac4b335efa93d22c9ce7b153cb5ce152 | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D175|Adult / Lineage, Cell type, age group and donor | 5.27e-04 | 168 | 42 | 3 | 14071b961c9bdb54a8259b12a88237b802cbde36 | |
| ToppCell | ASK428-Immune-Mast_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 5.27e-04 | 168 | 42 | 3 | c399fcb4d1d0be48026c2ecabc34a5935e7adf73 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.46e-04 | 170 | 42 | 3 | 92e765ae0d3adb38d3b22fddb873fd5ccad3fd44 | |
| ToppCell | severe_influenza-pDC|World / disease group, cell group and cell class (v2) | 5.46e-04 | 170 | 42 | 3 | b9c08af83241666bbdbed9109cadcd088c0f647d | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.46e-04 | 170 | 42 | 3 | 9f8b215caa1afa3cd7104c06fca7cfd790640f66 | |
| ToppCell | COVID-19_Convalescent-Hematopoietic_SC|COVID-19_Convalescent / Disease group, lineage and cell class | 5.46e-04 | 170 | 42 | 3 | 8a73d5334eed1cd9fdcc3ebeae0bdf9f945c228a | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.46e-04 | 170 | 42 | 3 | b49f7c8a27078de2137ed04f74cfee30729cfa5e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.46e-04 | 170 | 42 | 3 | 5d5f208682be21ed58320f5fc083a7898f8712da | |
| ToppCell | 3'_v3-bone_marrow-Mast-Mast_cell_lympho|bone_marrow / Manually curated celltypes from each tissue | 5.46e-04 | 170 | 42 | 3 | 4dedf482cd4521b3f87d2b5ae80f7a3ea8686a15 | |
| ToppCell | PBMC-Convalescent-Hematopoietic-HSPC|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.55e-04 | 171 | 42 | 3 | 172db31a37b72fb87fe5f0f79da51866b90dd1ad | |
| ToppCell | PBMC-Convalescent-Hematopoietic-HSPC-HSPC|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.55e-04 | 171 | 42 | 3 | 2031797d579ce373921affad70da6e50eec13664 | |
| ToppCell | ICU-SEP-Myeloid-pDC|ICU-SEP / Disease, Lineage and Cell Type | 5.55e-04 | 171 | 42 | 3 | 72c448a0dc4c569bd6b465f9aa395f38034e7ea6 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_LCN15|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.55e-04 | 171 | 42 | 3 | 9e00c8191ca9d52151a49baf39f8581cb176fb76 | |
| ToppCell | remission-HSPC|remission / disease stage, cell group and cell class | 5.55e-04 | 171 | 42 | 3 | 41b424e58470a2fc25632aea50a37c7c5ea17645 | |
| ToppCell | PBMC-Convalescent-Hematopoietic-HSPC-HSPC-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.55e-04 | 171 | 42 | 3 | a4e13b304ef414722ffdc06560deeab41785e956 | |
| ToppCell | Children_(3_yrs)-Immune-dendritic_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.55e-04 | 171 | 42 | 3 | 6a5ac0f56bd7b4543be103100fb735ca6bc5b8bf | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.65e-04 | 172 | 42 | 3 | 0c2d0bb767e5ce089b42ad49e8b303a103de2d5c | |
| ToppCell | PBMC-Convalescent-Hematopoietic-HSPC-HSPC-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.65e-04 | 172 | 42 | 3 | 8fd3db757d54949bd583d5f0eadf63a32342cb9d | |
| ToppCell | mild_COVID-19-pDC|World / disease group, cell group and cell class (v2) | 5.65e-04 | 172 | 42 | 3 | dab2f1a05c7df58d9387b13271b3f1f1583f9ac3 | |
| ToppCell | PBMC-Convalescent-Hematopoietic-HSPC-HSPC|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.65e-04 | 172 | 42 | 3 | 382cb5fea099110eb026a8bba6cf4c28763ea52f | |
| ToppCell | AT1-AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 5.65e-04 | 172 | 42 | 3 | 0be41df5d35d818deb7316ac21c9366eb4b7bfd1 | |
| ToppCell | PBMC-Convalescent-Hematopoietic-HSPC|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.65e-04 | 172 | 42 | 3 | da78f7a71b7f05c5c484c9ed19ba37c55d35e870 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.65e-04 | 172 | 42 | 3 | eeed177a03c116e9815a8e086d24efc9643b16a4 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Myeloid-cDC1|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.74e-04 | 173 | 42 | 3 | d13ae4046a25ee0fb492ddedf44583a879a432e9 | |
| ToppCell | 368C-Myeloid-Mast_cell|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 5.74e-04 | 173 | 42 | 3 | 8cffb4a37d30b6626188309b868ac4a62e91262f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.74e-04 | 173 | 42 | 3 | ecbf7167d4bec685e3460d826318544946f5f5c2 | |
| ToppCell | 368C-Myeloid-Mast_cell-|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 5.74e-04 | 173 | 42 | 3 | fb87ea74bf70aa83b458edf728c81857c8b8eb96 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.74e-04 | 173 | 42 | 3 | b8dc978c52de64afba21ff6cb32e79f07167448e | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.84e-04 | 174 | 42 | 3 | 9c916af5eebd932f67dc9117e1d26ff194a2ff2c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.84e-04 | 174 | 42 | 3 | bc71521f44a5fe013af42b06b5d1bd2446ecf3b5 | |
| ToppCell | COPD-Myeloid-pDC|World / Disease state, Lineage and Cell class | 5.84e-04 | 174 | 42 | 3 | be8227398300711ccda5ecc41ad34064bb246b19 | |
| ToppCell | severe_influenza-pDC|severe_influenza / disease group, cell group and cell class (v2) | 5.84e-04 | 174 | 42 | 3 | d8d2ded5812ed3b3db4109585714a6513c13326a | |
| ToppCell | IIF-Myeloid-pDC|IIF / Disease, Lineage and Cell Type | 5.94e-04 | 175 | 42 | 3 | 35cfb7d0b88678ff5b83ad6e19dbc15a908a3fcc | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-14|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.94e-04 | 175 | 42 | 3 | 87e557f7508c88b2087db5d57e77d5e2c92ca083 | |
| ToppCell | mild_COVID-19-pDC|mild_COVID-19 / disease group, cell group and cell class (v2) | 5.94e-04 | 175 | 42 | 3 | b87f279a7519710146c49d6acccb0adedc195965 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-Myeloid_Dendritic-pDC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.94e-04 | 175 | 42 | 3 | 37c2d4e0b6e9a3171931797ce9a54f3347288e57 | |
| ToppCell | IPF-Myeloid-pDC|World / Disease state, Lineage and Cell class | 5.94e-04 | 175 | 42 | 3 | a06785a4ded01adfd29ca4c20f7759eccbe274cb | |
| ToppCell | mild-Myeloid-pDC|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 6.04e-04 | 176 | 42 | 3 | 59a9c262c252b7d220a025837922d98e9d6b0a24 | |
| ToppCell | Thalamus-Neuronal-Excitatory|Thalamus / BrainAtlas - Mouse McCarroll V32 | 6.04e-04 | 176 | 42 | 3 | d2bbf13d21fb7582d7e5f90cd61a4ebe1cfccd66 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_DC-DC-tDC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.04e-04 | 176 | 42 | 3 | fb07a047a3a7a8d03bfcc28eea3da2eaa0f6b733 | |
| ToppCell | metastatic_Brain-Endothelial_cells-Lymphatic_ECs|Endothelial_cells / Location, Cell class and cell subclass | 6.04e-04 | 176 | 42 | 3 | 42541dfe20eb29625d47c0bb79bf3c21a2460340 | |
| ToppCell | CF-Lymphoid-pDC|CF / Disease state, Lineage and Cell class | 6.04e-04 | 176 | 42 | 3 | dd1e529a9e413bcaab43584afbe059e1464ffb53 | |
| ToppCell | ILEUM-inflamed-(3)_pDC|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.04e-04 | 176 | 42 | 3 | b9f847dd55703e413f3cd815eef5724fffaf13b3 | |
| ToppCell | Control-Myeloid-pDC|Control / Disease state, Lineage and Cell class | 6.14e-04 | 177 | 42 | 3 | 3940663bb5b45b2ca9f772550380a516c53e410b | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.14e-04 | 177 | 42 | 3 | 16197068260fc062bf8b730a51a199887ea580b9 | |
| ToppCell | tumor_Lung-Endothelial_cells-EPCs|tumor_Lung / Location, Cell class and cell subclass | 6.14e-04 | 177 | 42 | 3 | f8b152c09d56a97e8c0482fb1a3964c05f9dc8c5 | |
| ToppCell | COPD-Myeloid-pDC|COPD / Disease state, Lineage and Cell class | 6.14e-04 | 177 | 42 | 3 | 415aa023195a7f961c09529f65cdcc7bb90eaf5d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.24e-04 | 178 | 42 | 3 | c20f050344a2e120e685e2a7fe36c6dfc1dc37b6 | |
| ToppCell | Healthy/Control-pDC|Healthy/Control / Disease group and Cell class | 6.24e-04 | 178 | 42 | 3 | 072b346c6bbd63f00efaceda486400a669b3ec48 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-Myeloid-cDC2|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.24e-04 | 178 | 42 | 3 | 32120936a524c38e621bd2fca17524fef74422e0 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.24e-04 | 178 | 42 | 3 | 27497dbfcf9bb4dd0bf7caa0bd78c7e85f5c18ee | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.24e-04 | 178 | 42 | 3 | d348a9550db940d204706529759dc51e30506b5f | |
| ToppCell | IPF-Myeloid-pDC|IPF / Disease state, Lineage and Cell class | 6.24e-04 | 178 | 42 | 3 | 8d9e28492e1f157bac3308aa947fd864ca16d277 | |
| Drug | Melatonin [73-31-4]; Up 200; 17.2uM; MCF7; HT_HG-U133A | 1.40e-06 | 198 | 41 | 6 | 5393_UP | |
| Drug | dihydroclavaminate | 3.16e-06 | 2 | 41 | 2 | CID000441125 | |
| Drug | Dinoprost trometamol [38362-01-5]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 2.49e-05 | 194 | 41 | 5 | 3308_UP | |
| Drug | Sulfamethoxazole [723-46-6]; Up 200; 15.8uM; HL60; HT_HG-U133A | 2.62e-05 | 196 | 41 | 5 | 2335_UP | |
| Drug | Quinethazone [73-49-4]; Up 200; 13.8uM; PC3; HT_HG-U133A | 2.62e-05 | 196 | 41 | 5 | 3793_UP | |
| Drug | Ampyrone [83-07-8]; Down 200; 19.6uM; MCF7; HT_HG-U133A | 2.62e-05 | 196 | 41 | 5 | 2249_DN | |
| Drug | Flurbiprofen [5104-49-4]; Down 200; 16.4uM; PC3; HT_HG-U133A | 2.68e-05 | 197 | 41 | 5 | 4674_DN | |
| Drug | nordihydroguaiaretic acid; Up 200; 1uM; PC3; HT_HG-U133A | 2.68e-05 | 197 | 41 | 5 | 1223_UP | |
| Drug | Fursultiamine Hydrochloride [2105-43-3]; Up 200; 9.2uM; PC3; HT_HG-U133A | 2.75e-05 | 198 | 41 | 5 | 6630_UP | |
| Drug | Flucytosine [2022-85-7]; Down 200; 31uM; MCF7; HT_HG-U133A | 2.75e-05 | 198 | 41 | 5 | 6450_DN | |
| Drug | Thonzonium bromide [553-08-2]; Down 200; 6.8uM; HL60; HT_HG-U133A | 2.88e-05 | 200 | 41 | 5 | 3080_DN | |
| Drug | guanidinoproclavaminic acid | 6.61e-05 | 7 | 41 | 2 | CID000441124 | |
| Drug | deoxyguanidinoproclavaminate | 1.13e-04 | 9 | 41 | 2 | CID000441123 | |
| Drug | proclavaminate | 1.13e-04 | 9 | 41 | 2 | CID000194953 | |
| Drug | NSC-351324 | 1.26e-04 | 54 | 41 | 3 | CID000336564 | |
| Drug | R-Te | 1.48e-04 | 57 | 41 | 3 | CID000068913 | |
| Drug | PPCM | 1.64e-04 | 59 | 41 | 3 | CID000001292 | |
| Drug | trichloromethylium | 1.72e-04 | 11 | 41 | 2 | CID000157107 | |
| Drug | AC1L9QTR | 2.06e-04 | 12 | 41 | 2 | CID000453215 | |
| Drug | dibromochloromethane | 2.06e-04 | 12 | 41 | 2 | CID000031296 | |
| Drug | AC1L6D6Y | 2.06e-04 | 12 | 41 | 2 | CID000265082 | |
| Drug | EGEEA | 2.06e-04 | 12 | 41 | 2 | CID000008095 | |
| Drug | Puromycin dihydrochloride [58-58-2]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 2.19e-04 | 165 | 41 | 4 | 3310_UP | |
| Drug | CT-5 | 2.44e-04 | 13 | 41 | 2 | CID003034918 | |
| Drug | 8-aminohexylamino-cAMP | 2.84e-04 | 14 | 41 | 2 | CID000001906 | |
| Drug | AC1NFF1B | 2.84e-04 | 14 | 41 | 2 | CID004657542 | |
| Drug | Cmic | 2.84e-04 | 14 | 41 | 2 | CID000131448 | |
| Drug | C-S8 | 2.84e-04 | 14 | 41 | 2 | CID005287982 | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A | 3.04e-04 | 180 | 41 | 4 | 3787_UP | |
| Drug | AC1NOXKO | 3.27e-04 | 15 | 41 | 2 | CID005120672 | |
| Drug | ANDs | 3.27e-04 | 15 | 41 | 2 | CID000129830 | |
| Drug | fluphenazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A | 3.45e-04 | 186 | 41 | 4 | 5597_UP | |
| Drug | Tamoxifen citrate [54965-24-1]; Up 200; 7uM; MCF7; HT_HG-U133A | 3.52e-04 | 187 | 41 | 4 | 6768_UP | |
| Drug | Mepenzolate bromide [76-90-4]; Up 200; 9.6uM; PC3; HT_HG-U133A | 3.66e-04 | 189 | 41 | 4 | 4304_UP | |
| Drug | thiocarbonyl | 3.74e-04 | 16 | 41 | 2 | CID000108054 | |
| Drug | Dienestrol [84-17-3]; Up 200; 15uM; MCF7; HT_HG-U133A | 3.81e-04 | 191 | 41 | 4 | 3448_UP | |
| Drug | Halcinonide [3093-35-4]; Down 200; 8.8uM; PC3; HT_HG-U133A | 3.81e-04 | 191 | 41 | 4 | 7379_DN | |
| Drug | Monobenzone [103-16-2]; Up 200; 20uM; MCF7; HT_HG-U133A | 3.89e-04 | 192 | 41 | 4 | 3391_UP | |
| Drug | Clotrimazole [23593-75-1]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 3.97e-04 | 193 | 41 | 4 | 3166_UP | |
| Drug | Flucytosine [2022-85-7]; Down 200; 31uM; MCF7; HT_HG-U133A | 3.97e-04 | 193 | 41 | 4 | 5289_DN | |
| Drug | Altretamine [654-05-6]; Down 200; 19uM; MCF7; HT_HG-U133A | 4.04e-04 | 194 | 41 | 4 | 6467_DN | |
| Drug | Amyleine hydrochloride [532-59-2]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 4.04e-04 | 194 | 41 | 4 | 4169_DN | |
| Drug | radicicol; Up 200; 0.1uM; PC3; HT_HG-U133A | 4.12e-04 | 195 | 41 | 4 | 5952_UP | |
| Drug | Diethylstilbestrol [56-53-1]; Down 200; 15uM; PC3; HT_HG-U133A | 4.12e-04 | 195 | 41 | 4 | 3812_DN | |
| Drug | Ofloxacin [82419-36-1]; Up 200; 11uM; PC3; HT_HG-U133A | 4.12e-04 | 195 | 41 | 4 | 7372_UP | |
| Drug | carbamazepine; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA | 4.12e-04 | 195 | 41 | 4 | 919_UP | |
| Drug | CP-863187 [668981-07-5]; Up 200; 10uM; PC3; HT_HG-U133A | 4.20e-04 | 196 | 41 | 4 | 7512_UP | |
| Drug | Carbachol [51-83-2]; Up 200; 21.8uM; HL60; HT_HG-U133A | 4.20e-04 | 196 | 41 | 4 | 3042_UP | |
| Drug | Clorsulon [60200-06-8]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 4.20e-04 | 196 | 41 | 4 | 7025_UP | |
| Drug | Glibenclamide [10238-21-8]; Up 200; 8uM; HL60; HG-U133A | 4.20e-04 | 196 | 41 | 4 | 1546_UP | |
| Drug | Neomycin sulfate [1405-10-3]; Down 200; 4.2uM; MCF7; HT_HG-U133A | 4.20e-04 | 196 | 41 | 4 | 2229_DN | |
| Drug | Tocopherol (R,S) [10191-41-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 4.20e-04 | 196 | 41 | 4 | 3256_UP | |
| Drug | 0173570-0000 [211245-44-2]; Up 200; 10uM; PC3; HT_HG-U133A | 4.20e-04 | 196 | 41 | 4 | 3690_UP | |
| Drug | Lomefloxacin hydrochloride [98079-52-8]; Up 200; 10.4uM; PC3; HT_HG-U133A | 4.20e-04 | 196 | 41 | 4 | 4281_UP | |
| Drug | Methiazole; Up 200; 15uM; PC3; HT_HG-U133A | 4.20e-04 | 196 | 41 | 4 | 3796_UP | |
| Drug | Methoxamine hydrochloride [61-16-5]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 4.20e-04 | 196 | 41 | 4 | 4972_DN | |
| Drug | Nialamide [51-12-7]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 4.20e-04 | 196 | 41 | 4 | 4347_UP | |
| Drug | bromoform | 4.23e-04 | 17 | 41 | 2 | CID000005558 | |
| Drug | disilicon | 4.23e-04 | 17 | 41 | 2 | CID006327126 | |
| Drug | Flumequine [42835-25-6]; Up 200; 15.4uM; MCF7; HT_HG-U133A | 4.29e-04 | 197 | 41 | 4 | 2276_UP | |
| Drug | Noscapine [128-62-1]; Down 200; 9.6uM; PC3; HT_HG-U133A | 4.29e-04 | 197 | 41 | 4 | 5851_DN | |
| Drug | Diloxanide furoate [3736-81-0]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 4.29e-04 | 197 | 41 | 4 | 3399_DN | |
| Drug | Bretylium tosylate [61-75-6]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 4.29e-04 | 197 | 41 | 4 | 3394_DN | |
| Drug | Chlorphensin carbamate [886-74-8]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 4.29e-04 | 197 | 41 | 4 | 7472_UP | |
| Drug | Ursolic acid [77-52-1]; Up 200; 8.8uM; PC3; HT_HG-U133A | 4.29e-04 | 197 | 41 | 4 | 5825_UP | |
| Drug | Stachydrine hydrochloride; Up 200; 22.2uM; MCF7; HT_HG-U133A | 4.29e-04 | 197 | 41 | 4 | 6805_UP | |
| Drug | Althiazide [5588-16-9]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 4.29e-04 | 197 | 41 | 4 | 6089_UP | |
| Drug | Ramipril [87333-19-5]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 4.29e-04 | 197 | 41 | 4 | 6792_UP | |
| Drug | Methyldopate hydrochloride [2508-79-4]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 4.29e-04 | 197 | 41 | 4 | 7360_UP | |
| Drug | Amoxicillin [26787-78-0]; Up 200; 11uM; MCF7; HT_HG-U133A | 4.29e-04 | 197 | 41 | 4 | 2620_UP | |
| Drug | Methocarbamol [532-03-6]; Up 200; 16.6uM; MCF7; HT_HG-U133A | 4.29e-04 | 197 | 41 | 4 | 2274_UP | |
| Drug | Ivermectin [70288-86-7]; Up 200; 4.6uM; PC3; HT_HG-U133A | 4.29e-04 | 197 | 41 | 4 | 2051_UP | |
| Drug | PNU-0230031 [267429-39-0]; Up 200; 1uM; MCF7; HT_HG-U133A | 4.29e-04 | 197 | 41 | 4 | 3632_UP | |
| Drug | Tranylcypromine hydrochloride [1986-47-6]; Up 200; 23.6uM; MCF7; HT_HG-U133A | 4.37e-04 | 198 | 41 | 4 | 2264_UP | |
| Drug | Fusidic acid sodium salt [751-94-0]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 4.37e-04 | 198 | 41 | 4 | 2647_UP | |
| Drug | Minaprine dihydrochloride [25953-17-7]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 4.37e-04 | 198 | 41 | 4 | 1468_UP | |
| Drug | Ofloxacin [82419-36-1]; Down 200; 11uM; MCF7; HT_HG-U133A | 4.37e-04 | 198 | 41 | 4 | 4696_DN | |
| Drug | Mexiletine hydrochloride [5370-01-4]; Up 200; 18.6uM; PC3; HT_HG-U133A | 4.37e-04 | 198 | 41 | 4 | 3781_UP | |
| Drug | Ethisterone [434-03-7]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 4.37e-04 | 198 | 41 | 4 | 2326_UP | |
| Drug | Cortisone [53-06-5]; Down 200; 11uM; MCF7; HT_HG-U133A | 4.37e-04 | 198 | 41 | 4 | 7416_DN | |
| Drug | Bemegride [64-65-3]; Up 200; 25.8uM; HL60; HT_HG-U133A | 4.37e-04 | 198 | 41 | 4 | 3051_UP | |
| Drug | Carbinoxamine maleate salt [3505-38-2]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 4.37e-04 | 198 | 41 | 4 | 6786_UP | |
| Drug | Edrophonium chloride [116-38-1]; Up 200; 19.8uM; MCF7; HT_HG-U133A | 4.37e-04 | 198 | 41 | 4 | 1519_UP | |
| Drug | Cyclacillin [3485-14-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 4.37e-04 | 198 | 41 | 4 | 3882_DN | |
| Drug | Trimipramine maleate salt [521-78-8]; Up 200; 9.8uM; HL60; HT_HG-U133A | 4.37e-04 | 198 | 41 | 4 | 3004_UP | |
| Drug | (S)-(-)-Cycloserine [339-72-0]; Down 200; 39.2uM; MCF7; HT_HG-U133A | 4.45e-04 | 199 | 41 | 4 | 4346_DN | |
| Drug | Thiocolchicoside [602-41-5]; Down 200; 7uM; PC3; HT_HG-U133A | 4.45e-04 | 199 | 41 | 4 | 5095_DN | |
| Drug | Homochlorcyclizine dihydrochloride [1982-36-1]; Down 200; 10.4uM; HL60; HT_HG-U133A | 4.45e-04 | 199 | 41 | 4 | 2386_DN | |
| Drug | Karakoline [39089-30-0]; Up 200; 10.6uM; PC3; HT_HG-U133A | 4.45e-04 | 199 | 41 | 4 | 4297_UP | |
| Drug | Benoxinate hydrochloride [5987-82-6]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 4.45e-04 | 199 | 41 | 4 | 4115_UP | |
| Drug | Phenethicillin potassium salt [132-93-4]; Up 200; 10uM; MCF7; HT_HG-U133A | 4.45e-04 | 199 | 41 | 4 | 6105_UP | |
| Drug | Sulfabenzamide [127-71-9]; Down 200; 14.4uM; PC3; HT_HG-U133A | 4.45e-04 | 199 | 41 | 4 | 6634_DN | |
| Drug | Nitrofural [59-87-0]; Up 200; 20.2uM; MCF7; HT_HG-U133A | 4.45e-04 | 199 | 41 | 4 | 3320_UP | |
| Drug | 1,1-dimethylbiguanide hydrochloride; Down 200; 1000uM; MCF7; HG-U133A | 4.45e-04 | 199 | 41 | 4 | 4_DN | |
| Drug | Esculetin [305-01-1]; Down 200; 22.4uM; MCF7; HT_HG-U133A | 4.45e-04 | 199 | 41 | 4 | 6499_DN | |
| Drug | Cefsulodin sodium salt [52152-93-9]; Up 200; 7.2uM; MCF7; HT_HG-U133A | 4.54e-04 | 200 | 41 | 4 | 3328_UP | |
| Drug | Hesperidin [520-26-3]; Up 200; 6.6uM; MCF7; HT_HG-U133A | 4.54e-04 | 200 | 41 | 4 | 2648_UP | |
| Drug | rosiglitazone; Down 200; 10uM; MCF7; HT_HG-U133A | 4.54e-04 | 200 | 41 | 4 | 5230_DN | |
| Disease | mucinous adenocarcinoma (is_marker_for) | 1.79e-05 | 5 | 40 | 2 | DOID:3030 (is_marker_for) | |
| Disease | syndrome (implicated_via_orthology) | 2.70e-04 | 18 | 40 | 2 | DOID:225 (implicated_via_orthology) | |
| Disease | Cannabis use, age at onset | 3.02e-04 | 19 | 40 | 2 | EFO_0004847, EFO_0007585 | |
| Disease | body fat percentage | 4.95e-04 | 488 | 40 | 5 | EFO_0007800 | |
| Disease | glycine measurement | 8.53e-04 | 137 | 40 | 3 | EFO_0009767 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 1.47e-03 | 364 | 40 | 4 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | fibroblast growth factor 23 measurement | 1.56e-03 | 43 | 40 | 2 | EFO_0009381 | |
| Disease | response to hydrochlorothiazide, triglyceride measurement | 1.86e-03 | 47 | 40 | 2 | EFO_0004530, EFO_0005202 | |
| Disease | Hodgkins lymphoma | 5.56e-03 | 82 | 40 | 2 | EFO_0000183 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HDPDAKEKPLHMPGG | 481 | P48751 | |
| HHGNMKHPPGDKGEA | 251 | O43310 | |
| MDKHPGGLHPDNVKL | 221 | O94921 | |
| NPMEKHEGPGHGEDE | 886 | Q9H4D0 | |
| MPLPHEEKAAGGDLK | 676 | Q5JR59 | |
| EEGVEHDPGMPASKK | 1516 | Q96L73 | |
| VDPPMGEEGNHKRHS | 1026 | Q6PKG0 | |
| VPENGHHPKKQSDGM | 956 | A0AUZ9 | |
| PAEEKDGHSPMSKGL | 2656 | P78559 | |
| MEKAEGTPGPHKMEH | 911 | Q96JA1 | |
| GSHERPDKMLGPEHG | 976 | Q96NW7 | |
| GGHMEYKVDPEHLKE | 386 | Q9P2D0 | |
| GHGPSGKPMLHHGEK | 511 | Q9UN88 | |
| GKPMLHHGEKGVQEA | 516 | Q9UN88 | |
| PLMPEHSGGHLKSDP | 121 | O43593 | |
| KNIRPPHMKADHGDE | 446 | O00748 | |
| PHGEPVKVGHTVGMD | 5281 | P98088 | |
| HMKAVPGTEVPGHKN | 126 | Q76FK4 | |
| KSEVEEGHGKLPSMP | 1191 | P28290 | |
| MGNGSVKPKHSKHPD | 1 | Q13237 | |
| HDPHGLVVKSMPDPD | 1196 | Q52LW3 | |
| MLGCLHHPEEPEGKL | 36 | Q0VDD7 | |
| EKTDGMFKDGPVPAH | 296 | Q9Y3X0 | |
| VPGMHTEDNPGKVEH | 331 | P15260 | |
| SPEHPELHAELGMKP | 461 | Q96G74 | |
| PDPKLMDHGQSHPED | 246 | Q6UXV4 | |
| SPGHHHPPAVKEMKE | 56 | Q6ZWK4 | |
| EEPRNKHAMNPKGHS | 246 | P30414 | |
| MAGHPKEKVIPDEVH | 1 | A6NL82 | |
| GTMPFDGHDHKILVK | 246 | Q9H093 | |
| LGHGMPAKKEHKDHT | 141 | O94911 | |
| LPEGHMPEVAGLKGH | 4531 | Q8IVF2 | |
| DGHESAEPYAKHMKP | 106 | O60930 | |
| GHDAGDHPPITPMKS | 381 | O95985 | |
| PGIADSVMEPHKKGD | 281 | Q8IXK0 | |
| AHMKEKHPEPGGSCV | 661 | Q86UP3 | |
| MLSGDPHLKAAHIPE | 991 | P10745 | |
| PKLMDLHGKGHTGEK | 276 | Q92670 | |
| GEKHMLPGLSHNKEH | 1676 | Q92576 | |
| KKSMNHGKEGVPHEA | 441 | Q9HBF4 | |
| MSKHVGVHKGSLPPD | 676 | O15060 | |
| PKHGKEDPDNMPHVG | 1551 | A3KMH1 | |
| HGPKTKVAMREPEHS | 986 | P15822 | |
| LEAHMKEKHPEPGGS | 686 | Q15911 |